\
&
Contact us
\
&
Contact us
Published on | 6 months ago
ProgrammesThe European Partnership for Personalised Medicine (EP PerMed) has launched its first research, innovation and technology call for proposals (RITC 2026) on “Test and Demonstration of Multimodal Data Approaches for Personalised Medicine (MultiPMData2026)”. In total, 19 funding organisations participate in this call with an available budget of over € 14.8 Mio.
This call aims to bring together enterprises with clinical actors, including healthcare providers, patients, and researchers, to test innovative solutions in controlled real-world settings to address clear needs in managing multimorbidity.
EP PerMed will fund innovation projects in human health that focus on multimodal data usage for personalised medicine approaches providing more efficient and personalised management of patients with multimorbidity, having at least two chronic diseases that require management. While clinical studies can be funded, larger clinical trials are out of scope.
Flanders' Fund for Innovation and Entrepreneurship (VLAIO) participates in this call. More information on available funding for stakeholders based in Flanders and on how to apply can be found on the the dedicated EP PerMed webpage. Interested to apply? Contact VLAIO advisor Ariane.Tiberghien@vlaio.be.
The call will be implemented in two stages. Deadline for pre-proposal submission and for submission of the Flemish addendum via VLAIO is 12 January 2026 (14:00 CET). An info day itnroducing the RITC2026 will take place on 28 October 2025.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Culture and society Climate, Energy, Mobility EIC
OASC (Open & Agile Smart Cities & Communities) is a partner in the ACCEND project, a Europe-wide project building the foundations for a stronger, more connected deep tech scaleup scene. If you're developing solutions for Smart Cities, Net Zero Cities or Regenerative Cites, you might be interested in this opportunity to accelerate your... read more
ChemStream is an innovative chemical R&D company, specialized in translating material problems in sustainable formulations with focus on nano-dispersions, functional coatings and inkjet inks. Within LORCENIS they will develop super absorbing polymers (SAPs) to be mixed within the concrete matrices for improving the active internal curing, self-healing and self-sealing properties of the concrete. Grindig SAPs.
ChemStream bvba and Ghent University are involved in Horizon 2020-project for developing long lasting reinforced concrete for energy infrastructures.
